RYHTY (Ryman Healthcare) ROCE %: -4.92% (As of Mar. 2025)


RYHTY Ryman Healthcare Ltd RYHTY
70 GF Score
Price $6.11
GF Value $17.68
! 2 Warning Signs
View Full Analysis

What is Ryman Healthcare ROCE %?

Ryman Healthcare RYHTY -12.82% 70 ROCE % is -4.92% as of Mar. 2025. GuruFocus rates RYHTY with a GF Score™ of 70/100 and a GF Value™ of $17.68. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Ryman Healthcare's annualized ROCE % for the quarter that ended in Mar. 2025 was -4.92%.

Ryman Healthcare  (OTCPK:RYHTY) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Ryman Healthcare ROCE % Related Terms

Ryman Healthcare ROCE % Historical Data

* Premium members only.

The historical data trend for Ryman Healthcare's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ryman Healthcare ROCE % Chart

Ryman Healthcare Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.85 6.49 3.21 -0.76 -0.61

Ryman Healthcare Semi-Annual Data
Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.02 2.60 -4.13 3.67 -4.92
RYHTY
70GF Score
Ryman Healthcare Ltd RYHTY
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ryman Healthcare ROCE % Calculation

Ryman Healthcare's annualized ROCE % for the fiscal year that ended in Mar. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=-43.308/( ( (7958.687 - 227.162) + (6909.142 - 509.632) )/ 2 )
=-43.308/( (7731.525+6399.51)/ 2 )
=-43.308/7065.5175
=-0.61 %

Ryman Healthcare's ROCE % of for the quarter that ended in Mar. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2025 )  (Q: Sep. 2024 )(Q: Mar. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2025 )  (Q: Sep. 2024 )(Q: Mar. 2025 )
=-347.794/( ( (7974.411 - 242.444) + (6909.142 - 509.632) )/ 2 )
=-347.794/( ( 7731.967 + 6399.51 )/ 2 )
=-347.794/7065.7385
=-4.92 %

(1) Note: The EBIT data used here is two times the semi-annual (Mar. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -4.92% mean?
Ryman Healthcare (RYHTY) has a ROCE % of -4.92% as of Mar. 2025.
Is Ryman Healthcare's ROCE % too high?
Ryman Healthcare's current ROCE % is -4.92%. Overall, Ryman Healthcare has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Ryman Healthcare's ROCE % compare to HCA and THC?
Ryman Healthcare's ROCE % of -4.92% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ryman Healthcare's current ROCE % is -4.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ryman Healthcare stock overvalued right now?
Ryman Healthcare (RYHTY) has a current ROCE % of -4.92%. The stock's GF Value™ is $17.68, compared to a current price of $6.11 — trading 65.4% below its estimated fair value. The current ROCE % is -4.92%. Ryman Healthcare's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Ryman Healthcare (RYHTY), the current ROCE % is -4.92% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ryman Healthcare (RYHTY) Overvalued in 2026?

Based on GuruFocus' analysis, Ryman Healthcare stock appears to be undervalued. The current stock price of $6.11 is trading 65.4% below its estimated GF Value™ of $17.68.

Key valuation signals for RYHTY:

  • ROCE %: -4.92%
  • GF Value™: $17.68 vs. price of $6.11 (65.4% below fair value)
  • GF Score™: 70/100 with 2 warning signs

No single metric tells the full story. See the RYHTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ryman Healthcare Business Description

Address 92 Russley Road, P.O. Box 771, Christchurch, CT, NZL, 8042
Ryman Healthcare Ltd is a retirement living and aged care provider operating in New Zealand and Australia. It owns and operates integrated retirement villages through its trading subsidiaries, which operate in the aged care and retirement living sector in New Zealand and Australia. The Group operates in a single industry: the provision of integrated retirement living and aged care for older people in New Zealand and Australia. The majority of revenue is derived from Care and village fees, which relate to the provision of accommodation, care and related services to aged care residents and retirement living residents.
70GF Score

Get the complete analysis for RYHTY

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.11
Price
$17.68
GF Value